Importantly, pS225 dictates SIX1 function in glucose metabolism reprogramming as well as tumor growth and metastasis, because the phosphorylation-deficient mutant SIX1 (S225A) abolishes the ability of SIX1 to facilitate glycolytic gene expression, aerobic glycolysis, tumor growth and metastasis. This evidence concerns the gene SIX1 and neoplasm.